Long-Term Online Hemodiafiltration Does Not Reduce the Frequency and Severity of Acquired Cystic Kidney Disease in Hemodialysis Patients

REFERENCES

• Matson MA, Cohen EP. Acquired cystic kidney disease: Occurrence, prevalence, and renal cancers. Medicine (Baltimore). 1990; 69: 217–226
   PubMed Web of Science ®Google Scholar
• Levine E, Slusher SL, Grantham JJ, Wetzel LH. Natural history of acquired renal cystic disease in dialysis patients: A prospective longitudinal CT study. Am J Roentgenol. 1991; 156: 501–506
   PubMed Web of Science ®Google Scholar
• Moore AE, Kujubu DA. Spontaneous retroperitoneal hemorrhage due to acquired cystic kidney disease. Hemodial Int. 2007; 11((Suppl.) 3)S38–S40
   PubMedGoogle Scholar
• Gulanikar AC, Daily PP, Kilambi NK, Hamrick-Turner JE, Butkus DE. Prospective pretransplant ultrasound screening in 206 patients for acquired renal cysts and renal cell carcinoma. Transplantation. 1998; 66: 1669–1672
   PubMedGoogle Scholar
• Grantham JJ. Acquired cystic kidney disease. Kidney Int. 1991; 40: 143–152
   PubMed Web of Science ®Google Scholar
• Oya M, Mikami S, Mizuno R, Marumo K, Mukai M, Murai M. C-jun activation in acquired cystic kidney disease and renal cell carcinoma. J Urol. 2005; 174: 726
   PubMedGoogle Scholar
• Konda R, Sato H, Hatafuku F, Nozawa T, Ioritani N, Fujioka T. Expression of hepatocyte growth factor and its receptor C-met in acquired renal cystic disease associated with renal cell carcinoma. J Urol. 2004; 171: 2166–2170
   PubMedGoogle Scholar
• Konda R, Sugimura J, Sohma F, Katagiri T, Nakamura Y, Fujioka T. Over expression of hypoxia-inducible protein 2, hypoxia-inducible factor-1alpha and nuclear factor kappaB is putatively involved in acquired renal cyst formation and subsequent tumor transformation in patients with end stage renal failure. J Urol. 2008; 180: 481–485
   PubMedGoogle Scholar
• Cohen EP, Elliott WC, Jr. The role of ischemia in acquired cystic kidney disease. Am J Kidney Dis. 1990; 15: 55–60
   PubMedGoogle Scholar
• Master U, Cruz C, Schmidt R, Dumler F, Babiarz J. Renal malignancy in peritoneal dialysis patients with acquired cystic kidney disease. Adv Perit Dial. 1992; 8: 145–149
   PubMedGoogle Scholar
• Park JH, Kim YO, Kim BS, et al. Comparison of acquired cystic kidney disease between hemodialysis and continuous ambulatory peritoneal dialysis. Korean J Intern Med. 2000; 15: 51–55
   PubMedGoogle Scholar
• Acquired cystic kidney disease in children undergoing continuous ambulatory peritoneal dialysis. Kyushu Pediatric Nephrology Study Group. Am J Kidney Dis. 1999; 34: 242–246
   PubMedGoogle Scholar
• van der Weerd NC, Penne EL, van den Dorpel MA, et al. Hemodiafiltration: promise for the future?. Nephrol Dial Transplant. 2008; 23: 438–443
   PubMedGoogle Scholar
• Ishikawa I, Yuri T, Kitada H, Shinoda A. Regression of acquired cystic disease of the kidney after successful renal transplantation. Am J Nephrol. 1983; 3: 310–314
   PubMedGoogle Scholar
• Schwarz A, Vatandaslar S, Merkel S, Haller H. Renal cell carcinoma in transplant recipients with acquired cystic kidney disease. Clin J Am Soc Nephrol. 2007; 2: 750–756
   PubMedGoogle Scholar
• Ward RA, Schmidt B, Hullin J, Hillebrand GF, Samtleben W. A comparison of on-line hemodiafiltration and high-flux hemodialysis: A prospective clinical study. J Am Soc Nephrol. 2000; 11: 2344–2350
   PubMed Web of Science ®Google Scholar
• Lin CL, Yang CW, Chiang CC, Chang CT, Huang CC. Long-term on-line hemodiafiltration reduces predialysis beta-2-microglobulin levels in chronic hemodialysis patients. Blood Purif. 2001; 19: 301–307
   PubMedGoogle Scholar
• Lin CL, Huang CC, Yu CC, Yang HY, Chuang FR, Yang CW. Reduction of advanced glycation end product levels by on-line hemodiafiltration in long-term hemodialysis patients. Am J Kidney Dis. 2003; 42: 524–531
   PubMedGoogle Scholar
• Carracedo J, Merino A, Nogueras S, et al. On-line hemodiafiltration reduces the proinflammatory CD14+CD16+ monocyte-derived dendritic cells: A prospective, crossover study. J Am Soc Nephrol. 2006; 17: 2315–2321
   PubMedGoogle Scholar
• Nakai S, Iseki K, Tabei K, et al. Outcomes of hemodiafiltration based on Japanese dialysis patient registry. Am J Kidney Dis. 2001; 38: S212–S216
   PubMedGoogle Scholar
• Locatelli F, Marcelli D, Conte F, Limido A, Malberti F, Spotti D. Comparison of mortality in ESRD patients on convective and diffusive extracorporeal treatments. The Registro Lombardo Dialisi E Trapianto. Kidney Int. 1999; 55: 286–293
   PubMedGoogle Scholar
• Bonforte G, Grillo P, Zerbi S, Surian M. Improvement of anemia in hemodialysis patients treated by hemodiafiltration with high-volume on-line-prepared substitution fluid. Blood Purif. 2002; 20: 357–363
   PubMedGoogle Scholar
• Lin CL, Huang CC, Yu CC, et al. Improved iron utilization and reduced erythropoietin resistance by on-line hemodiafiltration. Blood Purif. 2002; 20: 349–356
   PubMedGoogle Scholar
• Christophe JL, van Ypersele de Strihou C, Pirson Y. Complications of autosomal dominant polycystic kidney disease in 50 hemodialysed patients. A case-control study. The U.C.L. Collaborative Group. Nephrol Dial Transplant. 1996; 11: 1271–1276
   PubMedGoogle Scholar
• Gabow PA, Johnson AM, Kaehny WD, Manco-Johnson ML, Duley IT, Everson GT. Risk factors for the development of hepatic cysts in autosomal dominant polycystic kidney disease. Hepatology. 1990; 11: 1033–1037
   PubMed Web of Science ®Google Scholar
• Sung CK, Kim SH, Ahn C. Grayscale and doppler ultrasonographic findings reflecting disease severity in autosomal dominant polycystic kidney disease. J Med Ultrasound. 2008; 16: 65–73
   Google Scholar
• Daugirdas JT. The post: pre-dialysis plasma urea nitrogen ratio to estimate K.t/V and NPCR: Mathematical modeling. Int J Artif Organs. 1989; 12: 411–419
   PubMed Web of Science ®Google Scholar
• Sargent JA. Control of dialysis by a single-pool urea model: The National Cooperative Dialysis Study. Kidney Int Suppl. 1983; S19–S25
   Google Scholar
• Canaud B, Morena M, Leray-Moragues H, Chalabi L, Cristol JP. Overview of clinical studies in hemodiafiltration: What do we need now?. Hemodial Int. 2006; 10(Suppl. 1)S5–S12
   Google Scholar
• Lien YH, Hunt KR, Siskind MS, Zukoski C. Association of cyclosporin A with acquired cystic kidney disease of the native kidneys in renal transplant recipients. Kidney Int. 1993; 44: 613–616
   PubMedGoogle Scholar
• Bolasco PG, Ghezzi PM, Ferrara R, et al. Effect of on-line hemodiafiltration with endogenous reinfusion (HFR) on the calcium-phosphorus metabolism: medium-term effects. Int J Artif Organs. 2006; 29: 1042–1052
   PubMedGoogle Scholar
• Beerenhout CH, Kooman JP, Luik AJ, Jeuken-Mertens SG, Van Der Sande FM, Leunissen KM. Optimizing renal replacement therapy—a case for online filtration therapies?. Nephrol Dial Transplant. 2002; 17: 2065–2070
   PubMed Web of Science ®Google Scholar
• Schiffl H. Prospective randomized cross-over long-term comparison of online hemodiafiltration and ultrapure high-flux hemodialysis. Eur J Med Res. 2007; 12: 26–33
   PubMed Web of Science ®Google Scholar
• Minutolo R, Bellizzi V, Cioffi M, et al. Postdialytic rebound of serum phosphorus: Pathogenetic and clinical insights. J Am Soc Nephrol. 2002; 13: 1046–1054
   PubMedGoogle Scholar
• Sarasin FP, Wong JB, Levey AS, Meyer KB. Screening for acquired cystic kidney disease: A decision analytic perspective. Kidney Int. 1995; 48: 207–219
   PubMed Web of Science ®Google Scholar